Usage Trends and Safety Profile of Recombinant Human Bone Morphogenetic Protein-2 for Spinal Column Tumor Surgery: A National Matched Cohort Analysis.

Global Spine J · 2025 · PMC11877595 · PMID 37542521

Europe PMC DOI

hedged sentence

0.1100

closest p · 2.2× alpha

0.1100

boldest claim

The sentences

a trend towards significanceP = .11not close (p > 0.1)

39 Interestingly, we discovered a lower mortality rate in the rhBMP-2 cohort at 1 year with a trend towards significance ( P = .11).

also in 2,760 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.